Viewing Study NCT04045795


Ignite Creation Date: 2025-12-24 @ 1:47 PM
Ignite Modification Date: 2025-12-27 @ 4:07 PM
Study NCT ID: NCT04045795
Status: COMPLETED
Last Update Posted: 2025-09-12
First Post: 2019-08-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module